60 Degrees Pharmaceuticals and GoodRx Partner to Lower Patient Out-of-Pocket Costs for Malaria Prevention Drug ARAKODA
ByAinvest
Monday, Feb 2, 2026 8:03 am ET1min read
GDRX--
60 Degrees Pharmaceuticals has partnered with GoodRx to offer eligible consumers savings of up to 30% on ARAKODA, the only FDA-approved, broad spectrum, once-weekly prescription malaria prevention medication. The partnership aims to lower patient out-of-pocket costs and expand access to the medication, which is available at over 70,000 pharmacies nationwide. ARAKODA is designed to prevent malaria, which is caused by the bite of the Anopheles mosquito and can be life-threatening if left untreated.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet